| NOBEL Pharma Schweiz AG - Eltrombopag NOBEL 50 mg, Filmtabletten | | 69450 | | 03 | | Eltrombopag NOBEL 50 mg | | Filmtabletten | | B02BX05 | | Eltrombopag | | 28.08.2024 | | |
| | Composition | | eltrombopagum 50 mg ut eltrombopagum olaminum, cellulosum microcristallinum, mannitolum, povidonum K 30, cellulosum microcristallinum silicificatum, carboxymethylamylum natricum A, glyceroli dibehenas, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, E 172 (flavum), macrogolum 400, E 172 (rubrum), pro compresso obducto corresp. natrium 7.242 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Eltrombopagum | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 172 | | color. | | Glyceroli Dibehenas | | | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Mannitol | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Titanium Dioxide | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 14 | PR | PR | A | | No | | 005 | 28 | PR | PR | A | | No |
|
|
